Rothschild & Co Asset Management US’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $103M | Buy |
2,225,689
+1,001,388
| +82% | +$46.3M | 1.57% | 17 |
|
|
2022
Q3 | $47.4M | Buy |
1,224,301
+30,858
| +3% | +$1.2M | 0.81% | 48 |
|
|
2022
Q2 | $44.5M | Buy |
1,193,443
+1,064,561
| +826% | +$39.7M | 0.68% | 51 |
|
|
2022
Q1 | $5.71M | Buy |
128,882
+4,092
| +3% | +$181K | 0.07% | 190 |
|
|
2021
Q4 | $5.3M | Sell |
124,790
-6,706
| -5% | -$285K | 0.06% | 213 |
|
|
2021
Q3 | $5.71M | Buy |
131,496
+16,838
| +15% | +$731K | 0.07% | 209 |
|
|
2021
Q2 | $4.9M | Sell |
114,658
-10,251
| -8% | -$438K | 0.06% | 221 |
|
|
2021
Q1 | $4.83M | Buy |
124,909
+257
| +0.2% | +$9.93K | 0.06% | 225 |
|
|
2020
Q4 | $4.48M | Sell |
124,652
-7,319
| -6% | -$263K | 0.06% | 234 |
|
|
2020
Q3 | $5.04M | Sell |
131,971
-215,183
| -62% | -$8.22M | 0.09% | 238 |
|
|
2020
Q2 | $12.2M | Buy |
+347,154
| New | +$12.2M | 0.18% | 196 |
|
|
2017
Q3 | – | Sell |
-15,053
| Closed | -$417K | – | 367 |
|
|
2017
Q2 | $417K | Sell |
15,053
-530
| -3% | -$14.7K | ﹤0.01% | 555 |
|
|
2017
Q1 | $388K | Sell |
15,583
-5,622
| -27% | -$140K | ﹤0.01% | 562 |
|
|
2016
Q4 | $459K | Buy |
21,205
+3,106
| +17% | +$67.2K | 0.01% | 533 |
|
|
2016
Q3 | $431K | Buy |
+18,099
| New | +$431K | 0.01% | 499 |
|